Patent holdings for IPC class G01N 30/50

Total number of patents in this class: 105

10-year publication summary

6
5
9
6
7
4
11
6
3
11
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Shimadzu Corporation
6187
6
Waters Technologies Corporation
1700
6
GE Healthcare Bio-Sciences AB
540
5
Regeneron Pharmaceuticals, Inc.
4303
5
Cytiva Sweden AB
764
4
Bristol-myers Squibb Company
4872
3
JSR Corporation
2526
3
Bio-Rad Laboratories, Inc.
1617
3
Quest Diagnostics Investments LLC
409
3
Repligen Corporation
285
3
Biotage AB
91
2
Genzyme Corporation
1269
2
Global Life Sciences Solutions USA LLC
502
2
Cytiva BioProcess R&D AB
306
2
F. Hoffmann-La Roche AG
7939
1
Hoffmann-La Roche Inc.
3454
1
ExxonMobil Research And Engineering Company
2566
1
Merck Patent GmbH
5814
1
Amgen Inc.
4093
1
Hitachi, Ltd.
15531
1
Other owners 50